Fig. 5.
Antitumor activity of ABD–immunotoxin fusion protein in nude mice. (A) Antitumor activity of LMB-164 in mesothelin expressing KLM1 xenograft. (B) Antitumor activity of LMB-164 and LMB-182 in mesothelin expressing KLM1 xenograft. (C) Antitumor activity of LMB-164, LMB-170, and LMB-172 in KLM1 xenograft. (D) Activity of LMB-12 and LMB-164 in A431/H9 xenograft.